See All Slides - tctmd.com

Slides

Presentation TCT 2013

Patients Receiving Novel Agents in Whom Life Threatening Bleeding: Practical Recommendations

Presenter: Christopher Granger

October 29, 2013

Presentation TCT 2013

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Presenter: Nils P. Johnson

October 29, 2013

Presentation

Welcome and Introductions/Pre-test

Presenter: Deepak Bhatt

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Approaches to NSVT After Alcohol Septal Ablation

Presenter: Michael Fifer

October 29, 2013

Presentation TCT 2013

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Presenter: 208788|Ricardo Costa

October 29, 2013

Presentation TCT 2013

How Do I Identify a Culprit Lesion?

Presenter: Takashi Kubo

October 29, 2013

Presentation TCT 2013

The Disutility of Nuisance Bleeding: Insights from the TRANSLATE ACS Registry

Presenter: Amit P. Amin

October 29, 2013

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation

Improving Outcomes: Clinical Case Review of the Direct Flow Medical System

Presenter: Antonio Colombo

October 29, 2013

Presentation TCT 2013

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Presenter: Michael Rinaldi

October 29, 2013

Advertisement

Slides

Patients Receiving Novel Agents in Whom Life Threatening Bleeding: Practical Recommendations

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Welcome and Introductions/Pre-test

Case Presentation and Topic Review: Approaches to NSVT After Alcohol Septal Ablation

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

How Do I Identify a Culprit Lesion?

The Disutility of Nuisance Bleeding: Insights from the TRANSLATE ACS Registry

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Improving Outcomes: Clinical Case Review of the Direct Flow Medical System

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content